New contact data of NETWORK
NETWORK by Post:
c/o Lichtblick GmbH
48317 Drensteinfurt - Germany
NETWORK by phone:
phone: +49 - 25 08 - 21 59 - 0
fax: +49 - 25 08 - 21 59 - 111
Anna G. Keller
phone: +49 - 25 08 - 21 59 - 200
Ulf Benwich / Ronja Bratsch
phone: +49 - 25 08 - 21 59 - 300
ATX-101 - New lipolysis drug in Phase 3 multicentre study
The American start-up Kythera Inc. and BAYER subsidiary Intendis cooperating on licensing of ATX-101....
Kythera is an American firm that has developed a drug going by the designation ATX-101 and based on patents held by Dr. Adam Rotunda (UCLA) and others. The sole active ingredient is deoxycholic acid, a bile acid which is also contained in Lipostabil.
In a double-blind multicentre study, Intendis has been pursuing the European licensing of this product since early 2011 as a drug intended for use in aesthetic treatments. The region designated for treatment is the double chin.
More Internet Information
Please visit also
NETWORK-AestheticMeso about Mesotherapy
NETWORK-Globalhealth about general medical issues
NETWORK-Cryodent about Parodontal Desease
ISL-International Society for Lipolysistherapy - Patient Information